Arcoma

Arcoma EPS

The Earnings per Share (EPS) of Arcoma (ARCOMA.ST) as of Oct 23, 2026 is 0.35 SEK. In the previous year, Earnings per Share (EPS) was 0.85 SEK — a change of -58.54% (lower).

EPS

0.35SEK

YoY

-58.54%

Last updated:

Earnings per Share (EPS) of Arcoma is 2025 0.35 SEK. Earnings per Share (EPS) of Arcoma was 2024 0.85 SEK. It decreases by -58.54% lower compared to the previous year.

The Arcoma EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
-0.58 SEK
Jan 1, 2022
0.14 SEK
Jan 1, 2023
0.19 SEK
Jan 1, 2024
0.85 SEK
Jan 1, 2025
0.35 SEK
Jan 1, 2026 (e)
0.55 SEK
Jan 1, 2027 (e)
0.75 SEK
Jan 1, 2028 (e)
0.80 SEK
The Arcoma EPS history
YEAREPSYoY
est0.80SEK+6.67%
est0.75SEK+36.36%
est0.55SEK+56.45%
0.35SEK-58.54%
0.85SEK+340.46%
0.19SEK+33.44%
0.14SEK-124.98%
-0.58SEK-640.62%
0.11SEK-79.57%
0.52SEK-516.77%
-0.13SEK-83.85%
-0.78SEK-31.01%
-1.13SEK+747.44%
-0.13SEK-805.58%
0.02SEK-114.04%
-0.13SEK-40.54%
-0.23SEK-68.43%
-0.71SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Earnings per Share (EPS) of Arcoma is 0.35 SEK in 2025.

Earnings per Share (EPS) of Arcoma changed from 0.85 SEK to 0.35 SEK, representing a -58.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Arcoma since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Arcoma

All Key Metrics — Arcoma